HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$5.91
Day range
$5.83 - $6.27
Year range
$0.66 - $14.30
Market cap
181.51M USD
Avg Volume
603.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.48M | -2.88% |
Net income | -8.22M | 6.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.65M | 18.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.71M | -56.61% |
Total assets | 31.22M | -53.57% |
Total liabilities | 25.24M | -8.51% |
Total equity | 5.98M | — |
Shares outstanding | 29.74M | — |
Price to book | 29.55 | — |
Return on assets | -54.56% | — |
Return on capital | -63.14% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.22M | 6.53% |
Cash from operations | -8.44M | 22.01% |
Cash from investing | -7.00K | -136.84% |
Cash from financing | -1.26M | — |
Net change in cash | -9.70M | 10.19% |
Free cash flow | -5.55M | 29.58% |
About
Founded
2003
Headquarters
Website
Employees
42